Understand the source comparison
Best Peptides for Post-Surgery Healing Research: Comparison
Before selecting peptides for a surgical recovery study, compare their mechanisms, optimal timing, and tissue-specific applications. BPC-157 VEGF receptor activation; angiogenesis in ischemic zones 0–72 hours post-surgery Muscle, tendon, gastric mucosa 250–500
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting peptides for a surgical recovery study, compare their mechanisms, optimal timing, and tissue-specific applications.
- BPC-157
- VEGF receptor activation; angiogenesis in ischemic zones
- 0–72 hours post-surgery
- Muscle, tendon, gastric mucosa
- 250–500 mcg/day (rodent models)
- Best for surgeries where vascular disruption limits healing. Orthopedic repairs, ischemic flaps
- TB-500
- Actin monomer sequestration; fibroblast migration
- Days 4–14 post-injury
- Dermis, fascia, skeletal muscle
- 2–5 mg per administration
- Strongest evidence in large wound beds requiring cell migration over distance
- GHK-Cu
- Lysyl oxidase activation; collagen crosslinking stabilization
- Weeks 3–8 (remodeling phase)
- Dermis, tendon, ligament
- 50–200 mcg/day
- Only peptide with evidence for improving tensile strength without increasing scar formation
- Ipamorelin
- GH secretagogue; systemic IGF-1 amplification
- Continuous administration starting pre-op
- Systemic (all tissues)
- 200–300 mcg twice daily
- Indirect support through metabolic pathways. Useful in catabolic patients or prolonged recovery
- PTD-DBM
- TGF-beta sequestration; inflammation resolution
- Days 1–7 post-surgery
- Cartilage, synovial tissue
- 100–500 mcg/day (emerging data)
- Experimental; limited availability but promising for inflammatory control in joint surgeries